Cellular and extracellular regulatory mechanisms of hypothalamic corticotropin-releasing hormone neurons

Endocrine Journal

Volumn 45, Issue 1, 1998, Pages 13-33

  Itoi, Keiichi ^a,b   Seasholtz, Audrey F ^b   Watson, Stanley J ^b  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; INTERLEUKIN 1; NEUROPEPTIDE Y; PROTEIN C FOS; PROTEIN KINASE C;

CATECHOLAMINE NERVE CELL; CORTICOTROPIN RELEASE; CYCLIC AMP RESPONSIVE ELEMENT; GENE CONTROL; HORMONAL REGULATION; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; NEGATIVE FEEDBACK; NEUROMODULATION; NONHUMAN; ONTOGENY; REVIEW; SEROTONINERGIC SYSTEM; TRANSLATION REGULATION;

EID: 0031899802     PISSN: 09188959     EISSN: None     Source Type: Journal    
DOI: 10.1507/endocrj.45.13     Document Type: Review

References (211)

1. Olschowka JA, O'Donohue TL, Mueller GP, Jacobowitz DM (1982) Hypothalamic and extrahypothalamic distribution of CRF-like immunoreactive neurons in the rat brain. Neuroendocrinology 35: 305-308.
2. Merchenthaler I, Vigh S, Petrusz P, Schally AV (1982) Immunocytochemical localization of corticotropin-releasing factor (CRF) in the rat brain. Am J Anat 165: 385-396.
3. Swanson LW, Sawchenko PE, Rivier J, Vale WW (1983) Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: An immunohistochemical study. Neuroendocrinology 36: 165-186.
4. Bloom FE, Battenberg ELF, Rivier J, Vale W (1982) Corticotropin-releasing factor (CRF): Immunoreactive neurons and fibers in rat hypothalamus. Regul Pept 4: 43-48.
5. Vale W, Spiess J, Rivier C, Rivier J (1981) Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 213: 1394-1397.
6. Furutani Y, Morimoto Y, Shibahara S, Noda M, Takahashi H, Hirose T, Asai M, Inayama S, Hayashida H, Miyata T, Numa S (1983) Cloning and sequence analysis of cDNA for ovine corticotropin-releasing factor precursor. Nature 301: 537-540.
7. Jingami H, Mizuno N, Takahashi H, Shibahara S, Furutani Y, Imura H, Numa S (1985) Cloning and sequence analysis of cDNA for rat corticotropin-releasing factor precursor. FEBS Lett 191: 63-66.
8. Shibahara S, Morimoto Y, Furutani Y, Notake M, Takahashi H, Shimizu S, Horikawa S, Numa S (1983) Isolation and sequence of the human corticotropin-releasing factor precursor gene. EMBO J 2: 775-779.
9. Thompson RC, Seasholtz AF, Herbert E (1987) Rat corticotropin-releasing hormone gene: Sequence and tissue-specific expression. Mol Endocrinol 1: 363-370.
10. Roche PJ, Crawford RJ, Fernley RT, Tregear GW, Coghlan JP (1988) Nucleotide sequence of the gene coding for ovine corticotropin-releasing factor and regulation of its mRNA levels by glucocorticoids. Gene 71: 421-431.
11. Seasholtz AF, Bourbonais FJ, Harnden CE, Camper SA (1991) Nucleotide sequence and expression of the mouse corticotropin-releasing hormone gene. Mol Cell Neurosci 2: 266-273.
12. Rivier CL, Plotsky PM (1986) Mediation by corticotropin-releasing factor (CRF) of adrenohypophysial hormone secretion. Ann Rev Physiol 48: 475-494.
13. Antoni FA (1986) Hypothalamic control of adrenocorticotropin secretion: Advances since the discovery of 41-residue corticotropin-releasing factor. Endocr Rev 7: 351-378.
14. Arbiser JL, Morton CC, Bruns GA, Majzoub JA (1988) Human corticotropin releasing hormone gene is located on the long arm of chromosome 8. Cytogenet Cell Genet 47: 113-116.
15. Knapp LT, Keegan CE, Seasholtz AF, Camper SA (1993) Corticotropin-releasing hormone (Crh) maps to mouse chromosome 3. Mamm Genome 4: 615-617.
16. Vamvakopoulos NC, Chrousos GP (1994) Hormonal regulation of human corticotropin-releasing hormone gene expression: Implications for the stress response and immune/inflammatory reaction. Endocr Rev 15: 409-420.
17. Sawchenko PE, Swanson LW, Vale WW (1984) Corticotropin-releasing factor: Coexpression within distinct subsets of oxytocin-, vasopressin-, and neurotensin-immunoreactive neurons in the hypothalamus of the male rat. J Neurosci 4: 1118-1129.
18. Mouri T, Suda T, Sasano N, Andoh N, Takei Y, Takase M, Sasaki A, Murakami O, Yoshinaga K (1984) Immunocytochemical identification of CRF in the human hypothalamus. Tohoku J Exp Med 142: 423-426.
19. Pelletier G, Desy L, Cote J, Vaudry H (1983) Immunocytochemical localization of corticotropin-releasing factor-like immunoreactivity in the human hypothalamus. Neurosci Lett 41: 259-263.
20. Mouri T, Itoi K, Takahashi K, Suda T, Murakami O, Yoshinaga K, Andoh N, Ohtani H, Masuda T, Sasano N (1993) Colocalization of corticotropin-releasing factor and vasopressin in the paraventricular nucleus of the human hypothalamus. Neuroendocrinology 57: 34-39.
21. Cummings S, Elde R, Ells J, Lindall A (1983) Corticotropin-releasing factor immunoreactivity is widely distributed within the central nervous system of the rat: An immunohistochemical study. J Neurosci 3: 1355-1368.
22. Sakanaka M, Shibasaki T, Lederis K (1987) Corticotropin releasing factor-like immunoreactivity in the rat brain as revealed by a modified cobalt-glucose oxidase-diaminobenzidine method. J Comp Neurol 260: 256-298.
23. Young WS III, Walker LC, Powers RE, De Souza EB, Price DL (1986) Corticotropin-releasing factor mRNA is expressed in the inferior olives of rodents and primates. Brain Res 387: 189-192.
24. Mezey E, Palkovits M (1991) Time dependent changes in CRF and its mRNA in the neurons of the inferior olive following surgical transection of the olivocerebellar tract in the rat. Mol Brain Res 10: 55-59.
25. Ju G, Swanson LW, Simerly RB (1989) Studies on the cellular architecture of the bed nuclei of the stria terminalis of the rat: IL Chemoarchitecture. J Comp Neurol 280: 603-621.
26. Imaki J, Imaki T, Vale W, Sawchenko PE (1991) Distribution of corticotropin-releasing factor mRNA and immunoreactivity in the central auditory system of the rat. Brain Res 547: 28-36.
27. Palkovits M, Leranth C, Gorcs T, Young WS III (1987) Corticotropin-releasing factor in the olivocerebellar tract of rats: Demonstration by light-and electron-microscopic immunohistochemistry and in situ hybridization histochemistry. Proc Natl Acad Sci USA 84: 3911-3915.
28. Keegan CE, Herman JP, Karolyi IJ, O'Shea KS, Camper SA, Seasholtz AF (1994) Differential expression of corticotropin-releasing hormone in developing mouse embryos and adult brain. Endocrinology 134: 2547-2555.
29. Suda T, Yajima F, Tomori N, Demura H, Shizume K (1985) In vitro study of immunoreactive corticotropin-releasing factor release from the rat hypothalamus. Life Sci 37: 1499-1505.
30. Emanuel RL, Girard DM, Thull DL, Majzoub JA (1990) Second messengers involved in the regulation of corticotropin-releasing hormone mRNA and peptide in cultured rat fetal hypothalamic primary cultures. Endocrinology 126: 3016-3021.
31. Seasholtz AF, Thompson RC, Douglass JO (1988) Identification of a cyclic adenosine monophosphate-responsive element in the rat corticotropin-releasing hormone gene. Mol Endocrinol 2: 1311-1319.
32. Spengler D, Rupprecht R, Van LP, Holsboer F (1992) Identification and characterization of a 3′,5′-cyclic adenosine monophosphate-responsive element in the human corticotropin-releasing hormone gene promoter. Mol Endocrinol 6: 1931-1941.
33. Dorin RI, Takahashi H, Nakai Y, Fukata J, Naitoh Y, Imura H (1989) Regulation of human corticotropin-releasing hormone gene expression by 3′,5′-cyclic adenosine monophosphate in a transfected mouse corticotroph cell line. Mol Endocrionol 3: 1537-1544.
34. Van LP, Spengler DH, Holsboer F (1990) Glucocorticoid repression of 3′,5′-cyclic-adenosine monophosphate-dependent human corticotropin-releasing-hormone gene promoter activity in a transfected mouse anterior pituitary cell line. Endocrinology 127: 1412-1418.
35. Guardiola-Diaz HM, Boswell C, Seasholtz AF (1994) The cAMP-responsive element in the corticotropin-releasing hormone gene mediates transcriptional regulation by depolarization. J Biol Chem 269: 14784-14791.
36. Itoi K, Horiba N, Tozawa F, Sakai Y, Sakai K, Abe K, Demura H, Suda T (1996) Major role of 3′,5′-cyclic adenosine monophosphate-dependent protein kinase A pathway in corticotropin-releasing factor gene expression in the rat hypothalamus. Endocrinology 137: 2389-2396.
37. Kovacs KJ, Sawchenko PE (1996) Sequence of stress-induced alterations in indices of synaptic and transcriptional activation in parvocellular neurosecretory neurons. J Neurosci 16: 262-273.
38. Vamvakopoulos NC, Chrousos GP (1993) Structural organization of the 5′ flanking region of the human corticotropin releasing hormone gene. DNA Sequence J 4: 197-206.
39. Vamvakopoulos NC, Chrousos GP (1993) Regulated activity of the distal promoter-like element of the human corticotropin-releasing hormone gene and secondary structural features of its corresponding transcripts. Mol Cell Endocrinol 94: 73-78.
40. Rosen LB, Majzoub JA, Adler GK (1992) Effects of glucocorticoid on corticotropin-releasing hormone gene regulation by second messenger pathways in NPLC and AtT-20 cells. Endocrinology 130: 2237-2244.
41. Adler GK, Rosen LB, Fiandaca MJ, Majzoub JA (1992) Protein kinase-C activation increases the quantity and poly (A) tail length of corticotropin-releasing hormone messenger RNA in NPLC cells. Mol Endocrinology 6: 476-484.
42. Suda T, Tozawa F, Yamada M, Ushiyama T, Tomori N, Sumitomo T, Nakagami Y, Demura H, Shizume K (1988) Insulin-induced hypoglycemia increases corticotropin-releasing factor messenger ribonucleic acid levels in rat hypothalamus. Endocrinology 123: 1371-1375.
43. Herman JP, Schafer MK-H, Thompson RC, Watson SJ (1992) Rapid regulation of corticotropin-releasing hormone gene transcription in vivo. Mol Endocrinol 6: 1061-1069.
44. Bugnon C, Fellmann D, Gouget A (1983) Changes in corticoliberin and vasopressin-like immunoreactivities in the zona externa of the median eminence in adrenalectomized rats. Immunocytochemical study. Neurosci Lett 37: 43-49.
45. Kiss JZ, Mezey E, Skirboll L (1984) Corticotropin-releasing factor-immunoreactive neurons of the paraventricular nucleus become vasopressin positive after adrenalectomy. Proc Natl Acad Sci USA 81: 1854-1858.
46. Itoi K, Mouri T, Takahashi K, Murakami O, Imai Y, Sasaki S, Yoshinaga K, Sasano N (1987) Suppression by glucocorticoid of the immunoreactivity of corticotropin-releasing factor and vasopressin in the paraventricular nucleus of rat hypothalamus. Neurosci Lett 73: 231-236.
47. Jingami H, Matsukura S, Numa S, Imura H (1985) Effects of adrenalectomy and dexamethasone administration on the level of prepro-corticotropin-releasing factor messenger ribonucleic acid (mRNA) in the hypothalamus and adrenocorticotropin/b-lipotropin precursor mRNA in the pituitary in rats. Endocrinology 117: 1314-1320.
48. Swanson LW, Simmons DM (1989) Differential steroid hormone and neural influence on peptide mRNA levels in CRH cells of the paraventricular nucleus: A hybridization histochemical study in the rat. J Comp Neurol 285: 413-435.
49. Beyer HS, Matta SG, Sharp BM (1988) Regulation of the messenger ribonucleic acid for corticotropin-releasing factor in the paraventricular nucleus and other brain sites of the rat. Endocrinology 123: 2117-2123.
50. Plotsky PM, Sawchenko PE (1987) Hypophysial-portal plasma levels, median eminence content, and immunohistochemical staining of corticotropin-releasing factor, arginine vasopressin, and oxytocin after pharmacological adrenalectomy. Endocrinology 120: 1361-1369.
51. Kovacs K, Kiss JZ, Makara GB (1986) Glucocorticoid implants around the hypothalamic paraventricular nucleus prevent the increase of corticotropin-releasing factor and arginine vasopressin immunostaining induced by adrenalectomy. Neuroendocrinology 44: 229-234.
52. Kovacs KJ, Mezey E (1987) Dexamethasone inhibits corticotropin-releasing factor gene expression in the rat paraventricular nucleus. Neuroendocrinology 46: 365-368.
53. Sawchenko PE (1987) Evidence for a local site of action for glucocorticoids in inhibiting CRF and vasopressin expression in the paraventricular nucleus. Brain Res 403: 213-224.
54. Adler GK, Smas CM, Majzoub JA (1988) Expression and dexamethasone regulation of the human corticotropin-releasing hormone gene in a mouse anterior pituitary cell line. J Biol Chem 263: 5846-5852.
55. Roberts JL, Budarf ML, Baxter JD, Herbert E (1979) Selective reduction of proadrenocorticotropin/ endorphin proteins and mRNA activity in mouse pituitary tumor cells by glucocorticoids. Biochemistry 18: 4907-4915.
56. Birnberg NC, Lissitzky JC, Hinman M, Herbert E (1983) Glucocorticoids regulate proopiomelanocortin gene expression in vivo at the levels of transcription and secretion. Proc Natl Acad Sci USA 80: 6982-6986.
57. Drouin J, Trifiro MA, Plante RK, Nemer M, Eriksson P, Wrange O (1989) Glucocorticoid receptor binding to a specific DNA sequence is required for hormone-dependent repression of pro-opiomelanocortin gene transcription. Mol Cell Biol 9: 5305-5314.
58. Jonat C, Rahmsdorf HJ, Park K-K, Cato ACB, Gebel S, Ponta H, Herrlich P (1990) Antitumor promotion and antiinflammation: Down-modulation of AP-1 (fos/jun) activity by glucocorticoid hormone. Cell 62: 1189-1204.
59. Akerblom IE, Slater EP, Beato M, Baxter JD, Mellon PL (1988) Negative regulation by glucocorticoids through interference with a cAMP responsive enhancer. Science 241: 350-353.
60. Chatterjee VK, Madison LD, Mayo S, Jameson JL (1991) Repression of the human glycoprotein hormone alpha subunit gene by glucocorticoids: Evidence for receptor interactions with limiting transcriptional activators. Mol Endocrinol 5: 100-110.
61. Camper SA, Yao YAS, Rottman FM (1985) Hormonal regulation of the bovine prolactin promoter in rat pituitary tumor cells. J Biol Chem 260: 12246-12251.
62. Sakai DD, Helms S, Carlstedt-Duke J, Gustafsson JA, Rottman FM, Yamamoto KR (1988) Hormone-mediated repression: A negative glucocorticoid responsive element from the bovine prolactin gene. Genes Dev 2: 1144-1154.
63. Diamond MI, Miner JN, Yoshinaga SK, Yamamoto KR (1990) Transcription factor interactions: Selectors of positive or negative regulation from a single DNA element. Science 249: 1266-1272.
64. Morrison N, Eisman J (1993) Role of the negative glucocorticoid regulatory element in glucocorticoid repression of the human osteocalcin promoter. J Bone Miner Res 8: 969-975.
65. Guardiola-Diaz HM, Kolinske JS, Gates LH, Seasholtz AF (1996) Negative glucocorticoid regulation of cyclic adenosine 3′,5′-monophosphate-stimulated corticotropin-releasing hormone-reporter expression in AtT-20 cells. Mol Endocrinol 10: 317-329.
66. Malkoski SP, Handanos CM, Dorin RI (1997) Localization of a negative glucocorticoid response element of the human corticotropin releasing hormone gene. Mol Cell Endocrinol 127: 189-199.
67. Grino M, Young WS III, Burgunder J-M (1989) Ontogeny of expression of the corticotropin-releasing factor gene in the hypothalamic paraventricular nucleus and of the proopiomelanocortin gene in rat pituitary. Endocrinology 124: 60-68.
68. Daikoku S, Okamura Y, Kawano H, Tsuruo Y, Maegawa M, Shibasaki T (1984) Immunohistochemical study on the development of CRF-containing neurons in the hypothalamus of the rat. Cell Tissue Res 238: 539-544.
69. Bugnon C, Fellmann D, Gouget A, Cardot J (1982) Ontogeny of the corticoliberin neuroglandular system in rat brain. Nature 298: 159-161.
70. Walker C-D, Perrin M, Vale W, Rivier C (1986) Ontogeny of the stress response in the rat: Role of the pituitary and the hypothalamus. Endocrinology 118: 1445-1451.
71. Sapolsky RM, Meaney MJ (1986) Maturation of the adrenocortical stress response: Neuroendocrine control mechanisms and the stress hyporesponsive period. Brain Res Rev 11: 65-76.
72. Meaney MJ, Sapolsky RM, McEwen BS (1985) The development of the glucocorticoid receptor system in the rat limbic brain. I. Ontogeny and autoregulation. Brain Res 350: 159-164.
73. Keegan CE, Karolyi IJ, Knapp LT, Bourbonais FJ, Camper SA, Seasholtz AF (1994) Expression of corticotropin-releasing hormone transgenes in neurons of adult and developing mice. Mol Cell Neurosci 5: 505-514.
74. Keegan CE, Karolyi IJ, Burrows HL, Camper SA, Seasholtz AF (1994) Homologous recombination in fertilized mouse eggs and assessment of heterologous locus control region function. Transgenics 1: 439-449.
75. Plotsky PM, Cunningham ET Jr, Widmaier EP (1989) Catecholaminergic modulation of corticotropin-releasing factor and adrenocorticotropin secretion. Endocr Rev 10: 437-458.
76. Sawchenko PE, Swanson LW (1981) Central noradrenergic pathways for the integration of hypothalamic neuroendocrine and autonomic responses. Science 214: 685-687.
77. Sawchenko PE, Swanson LW (1982) The organization of noradrenergic pathways from the brainstem to the paraventricular and supraoptic nuclei in the rat. Brain Res Rev 4: 275-325.
78. Swanson LW, Sawchenko PE (1983) Hypothalamic integration: Organization of the paraventricular and supraoptic nuclei. Annu Rev Neurosci 6: 269-324.
79. Cunningham ET Jr, Sawchenko PE (1988) Anatomical specificity of noradrenergic inputs to the paraventricular and supraoptic nuclei of the rat hypothalamus. J Comp Neurol 274: 60-76
80. Cunningham ET Jr, Bohn MC, Sawchenko PE (1990) Organization of adrenergic inputs to the paraventricular and supraoptic nuclei of the hypothalamus in the rat. J Comp Neurol 292: 651-667.
81. Liposits Z, Phelix C, Paull WK (1986) Electron microscopic analysis of tyrosine hydroxylase, dopamine-β-hydroxylase and phenylethanolamine-N-methyltransferase immunoreactive innervation of the hypothalamic paraventricular nucleus in the rat. Histochemistry 84: 105-120.
82. Van Loon GR, Scapagnini U, Cohen R, Ganong WF (1971) Effect of intraventricular administration of adrenergic drugs on the adrenal venous 17-hydroxycorticosteroid response to surgical stress in the dog. Neuroendocrinology 8: 257-272.
83. Szafarczyk A, Malaval F, Laurent A, Gibaud R, Assenmacher I (1987) Further evidence for a central stimulatory action of catecholamines on adrenocorticotropin release in the rat. Endocrinology 121: 883-892.
84. Leibowitz SF, Diaz S, Tempel D (1989) Norepinephrine in the paraventricular nucleus stimulates corticosterone. Brain Res 496: 219-227.
85. Itoi K, Suda T, Tozawa F, Dobashi I, Ohmori N, Sakai Y, Abe K, Demura H (1994) Microinjection of norepinephrine into the paraventricular nucleus of the hypothalamus stimulates corticotropin-releasing factor gene expression in conscious rats. Endocrinology 135: 2177-2182.
86. Liu J-P, Clarke IJ, Funder JW, Engler D (1991) Evidence that the central noradrenergic pathways activate the hypothalamic-pituitary-adrenal axis in the sheep. Endocrinology 129: 200-209.
87. Plotsky PM (1987) Facilitation of immunoreactive corticotropin-releasing factor secretion into the hypophysial-portal circulation after activation of catecholaminergic pathways or central norepinephrine injection. Endocrinology 121: 924-930.
88. Widmaier EP, Lim AT, Vale W (1989) Secretion of corticotropin-releasing factor from cultured rat hypothalamic cells: Effects of catecholamines. Endocrinology 124: 583-590.
89. Buckingham JC, Hodges JR (1979) Hypothalamic receptors influencing the secretion of corticotrophin releasing hormone in the rat. J Physiol (Lond) 290: 421-431.
90. Fehm HL, Voigt KH, Lang RE, Pfeiffer EF (1980) Effects of neurotransmitters on the release of corticotropin releasing hormone (CRH) by rat hypothalamic tissue in vitro. Exp Brain Res 39: 229-234.
91. Suda T, Yajima F, Tomori N, Sumitomo T, Nakagami Y, Ushiyama T, Demura H, Shizume K (1987) Inhibitory effect of norepinephrine on immunoreactive corticotropin-releasing factor release from the rat hypothalamus in vitro. Life Sci 40: 1645-1649.
92. Tsagarakis S, Holly JMP, Rees LH, Besser GM, Grossman A (1988) Acetylcholine and norepinephrine stimulate the release of corticotropin-releasing factor-41 from the rat hypothalamus in vitro. Endocrinology 123: 1962-1969.
93. Calogero AE, Gallucci WT, Chrousos GP, Gold PW (1988) Catecholamine effects upon rat hypothalamic corticotropin-releasing hormone secretion in vitro. J Clin Invest 82: 839-846.
94. Palkovits M (1987) Anatomy of neural path-ways affecting CRH secretion. Ann NY Acad Sci 512: 139-148.
95. Alonso G, Szafarczyk A, Balmefrezol M, Assenmacher I (1986) Immunocytochemical evidence for stimulatory control by the ventral noradrenergic bundle of parvocellular neurons of the paraventricular nucleus secreting corticotropin releasing hormone and vasopressin in rats. Brain Res 397: 297-307.
96. Szafarczyk A, Alonso G, Ixart G, Malaval F, Assenmacher I (1985) Diurnal-stimulated and stress-induced ACTH release in rats is mediated by ventral noradrenergic bundle. Am J Physiol 249: E219-E226.
97. Sawchenko PE (1988) Effects of catecholamine-depleting medullary knife cuts on corticotropin-releasing factor and vasopressin immunoreactivity in the hypothalamus of normal and steroid-manipulated rats. Neuroendocrinology 48: 459-470.
98. Pacak K, Armando I, Fukuhara K, Kvetnansky R, Palkovits M, Kopin I, Goldstein DS (1992) Noradrenergic activation in the paraventricular nucleus during acute and chronic immobilization stress in rats: An in vivo microdialysis study. Brain Res 589: 91-96.
99. Pacak K, Palkovits M, Kvetnansky R, Kopin IJ, Goldstein DS (1993) Stress-induced norepinephrine release in the paraventricular nucleus of rats with brainstem hemisections: A microdialysis study. Neuroendocrinology 58: 196-201.
100. Guillaume V, Conte-Devolx B, Szafarczyk A, Malaval F, Pares-Herbute N, Grino M, Alonso G, Assenmacher I, Oliver C (1987) The corticotropin-releasing factor release in rat hypophysial portal blood is mediated by brain catecholamines. Neuroendocrinology 46: 143-146.
101. Harbuz MS, Chowdrey HS, Jessop DS, Biswas S, Lightman SL (1991) Role of catecholamines in mediating messenger RNA and hormonal responses to stress. Brain Res 551: 52-57.
102. Mezey E, Kiss JS, Skirboll LR, Goldstein M, Axelrod J (1984) Increase of corticotropin-releasing factor staining in rat paraventricular nucleus neurones by depletion of hypothalamic adrenaline. Nature 310: 140-141.
103. Plotsky PM, Otto S, Sutton S (1987) Neurotransmitter modulation of corticotropin releasing factor secretion into the hypophysial-portal circulation. Life Sci 41: 1311-1317.
104. Spinedi E, Johnston CA, Chisari A, Negro-Vilar A (1988) Role of central epinephrine on the regulation of corticotropin-releasing factor and adrenocorticotropin secretion. Endocrinology 122: 1977-1983.
105. Kiss A, Aguilera G (1992) Participation of α1-adrenergic receptors in the secretion of hypothalamic corticotropin-releasing hormone during stress. Neuroendocrinology 56: 153-160.
106. Whitnall MH, Kiss A, Aguilera G (1993) Contrasting effects of central alpha-1-adrenoreceptor activation on stress-responsive and stress-nonresponsive subpopulations of corticotropin-releasing hormone neurosecretory cells in the rat. Neuroendocrinology 58: 42-48.
107. Young WS III, Kuhar MJ (1980) Noradrenergic α1 and α2 receptors: Light microscopic autoradiographic localization. Proc Natl Acad Sci USA 77: 1696-1700.
108. Leibowitz SF, Jhanwar-Uniyal M, Dvorkin B, Makman MH (1982) Distribution of α-adrenergic, β-adrenergic and dopaminergic receptors in discrete hypothalamic areas of rat. Brain Res 233: 97-114.
109. 125I]iodocyanopindolol. Brain Res 261: 249-259.
110. 125I]-HEAT. J Comp Neurol 231: 190-208.
111. Lachuer J, Gaillet S, Barbagli B, Buda M, Tappaz M (1991) Differential early time course activation of the brainstem catecholaminergic groups in response to various stresses. Neuroendocrinology 53: 589-596.
112. Hillhouse EW, Burden J, Jones MT (1975) The effect of various putative neurotransmitters on the release of corticotropin releasing hormone from the hypothalamus of the rat in vitro. I. The effect of acetylcholine and noradrenaline. Neuroendocrinology 17: 1-11.
113. Calogero AE, Gallucci WT, Bernardini R, Saoutis C, Gold PW, Chrousos GP (1988) Effect of cholinergic agonists and antagonists on rat hypothalamic corticotropin-releasing hormone secretion in vitro. Neuroendocrinology 47: 303-308.
114. Hillhouse EW, Milton NGN (1989) Effect of acetylcholine and 5-hydroxytryptamine on the secretion of corticotropin-releasing factor-41 and arginine vasopressin from the rat hypothalamus in vitro. J Endocrinol 122: 713-718.
115. Suda T, Yajima F, Tomori N, Sumitomo T, Nakagami Y, Ushiyama T, Demura H, Shizume K (1987) Stimulatory effect of acetylcholine on immunoreactive corticotropin-releasing factor release from the rat hypothalamus in vitro. Life Sci 40: 673-677.
116. Hillhouse E, Reichlin S (1990) Acetylcholine stimulates the secretion of corticotropin-releasing factor from primary dissociated cell culture of the rat telencephalon and diencephalon. Brain Res 506: 9-13.
117. Hedge GA, Smelik PG (1968) Corticotropin release: Inhibition by intrahypothalamic implantation of atropine. Science 159: 891-892.
118. Calogero AE, Kamilaris TC, Gomez MT, Johnson EO, Tartaglia ME, Gold PW, Chrousos GP (1989) The muscarinic cholinergic agonist arecoline stimulates the rat hypothalamic-pituitary-adrenal axis through a centrally-mediated corticotropin-releasing hormone-dependent mechanism. Endocrinology 125: 2445-2453.
119. Ohmori N, Itoi K, Tozawa F, Sakai Y, Sakai K, Horiba N, Demura H, Suda T (1995) Effect of acetylcholine on corticotropin-releasing factor gene expression in the hypothalamic paraventricular nucleus of conscious rats. Endocrinology 136: 4858-4863.
120. Hunt S, Schmidt J (1978) Some observations on the binding patterns of α-bungarotoxin in the central nervous system of the rat. Brain Res 157: 213-232.
121. 3H]propylbenzilylcholine mustard and its distribution in the forebrain. Brain Res Rev 1: 141-165.
122. Mash DC, Potter LT (1986) Autoradiographic localization of M1 and M2 muscarine receptors in the rat brain. Neuroscience 19: 551-564.
123. Ball GF, Nock B, Wingfield JC, McEwen BS, Balthazart J (1990) Muscarinic cholinergic receptors in the songbird and quail brain: A quantitative autoradiographic study. J Comp Neurol 298: 431-442.
124. Wada E, Wada K, Boulter J, Deneris E, Heinemann S, Patrick J, Swanson LW (1989) Distribution of alpha2, alpha3, alpha4, and beta2, neuronal nicotinic receptor subunit mRNAs in the central nervous system: A hybridization histochemical study in the rat. J Comp Neurol 284: 314-335.
125. Okuda H, Shioda S, Nakai Y, Nakayama H, Okamoto M, Nakashima T (1993) Immuocytochemical localization of nicotinic acetylcholine receptor in rat hypothalamus. Brain Res 625: 145-151.
126. Vilaro MT, Palacios JM, Mengot G (1990) Localization of m5 muscarinic receptor mRNA in rat brain examined by in situ hybridization histochemistry. Neurosci Lett 114: 154-159.
127. Vilaro MT, Wiederhold K-H, Palacios JM, Mengold G (1992) Muscarinic M2 receptor mRNA expression and receptor binding in cholinergic and non-cholinergic cells in the rat brain. A correlative study using in situ hybridization histochemistry and receptor autoradiography. Neuroscience 47: 367-393.
128. Ruggiero DA, Giuliano R, Anwar M, Stornetta R, Reis DJ (1990) Anatomical substrates of cholinergic-autonomic regulation in the rat. J Comp Neurol 292: 1-53.
129. Oorjithan EG, Dodfrey DA, Ross CD, Dunn JD (1989) Effect of septal ablation on choline acetyltransferase in the paraventricular nucleus. Brain Res Bull 22: 277-282.
130. Butcher LL, Woolf NJ (1984) Histochemical distribution of acetylcholinesterase in the central nervous system: Clues to the localization of cholinergic neurons. In: Bjorklund A, Hokfelt T, Kuhar MJ (eds) Handbook of Chemical Neuroanatomy. Elsevier, Amsterdam, vol 3: 1-50.
131. Kimura H, McGeer P, Peng J-H (1984) Choline acetyltransferase-containing neurons in the rat brain. In: Bjorklund A, Hokfelt T, Kuhar MJ (eds) Handbook of Chemical Neuroanatomy. Elsevier, Amsterdam, vol 3: 51-67.
132. Rye DB, Saper CB, Lee HJ, Wainer BH (1987) Pedunculopontine tegmental nucleus of the rat: Cytoarchitecture, cytochemistry, and some extrapyramidal connections of the mesopontine tegmentum. J Comp Neurol 259: 483-528.
133. Saper CB, Loewy AD (1980) Efferent connections of the parabrachial nucleus in the rat. Brain Res 197: 291-317.
134. Sawchenko PE, Swanson LW, Steinbusch HWM, Verhofstad AAJ (1983) The distribution and cells of origin of serotonergic inputs to the paraventricular nuclei of the rat. Brain Res 277: 355-360.
135. Lipisits Z, Phelix C, Paull WK (1987) Synaptic interaction of serotonergic axons and corticotropin releasing factor (CRF) synthesizing neurons in the hypothalamic paraventricular nucleus of the rat. Histochemistry 86: 541-549.
136. Saphier D, Feldman S (1989) Paraventricular nucleus neuronal responses following electrical stimulation of the midbrain dorsal raphe: Evidence for cotransmission. Exp Brain Res 78: 407-414.
137. Nakagami Y, Suda T, Yajima F, Ushiyama T, Tomori N, Sumitomo T, Demura H, Shizume K (1986) Effects of serotonin, cyproheptadine and reserpine on corticotropin-releasing factor release from the rat hypothalamus in vitro. Brain Res 386: 232-236.
138. Gibbs DM, Vale W (1983) Effect of the serotonin reuptake inhibitor fluoxetine on corticotropin-releasing factor and vasopressin secretion into hypophysial portal blood. Brain Res 280: 176-179.
139. Korte SM, Van Duin S, Bouws GAH, Koolhaas JM, Bohus B (1991) Involvement of hypothalamic serotonin in activation of the sympatho-adrenomedullary system and hypothalamic-pituitary-adrenocortical axis in male Wistar rats. Eur J Pharmacol 197: 225-228.
140. Inagaki N, Yamatodani A, Ando-Yamamoto M, Tohyama M, Watanabe T, Wada H (1988) Organization of histaminergic fibers in the rat brain. J Comp Neurol 273: 283-300.
141. Kjaer A, Knigge U, Bach FW, Warberg J (1992) Histamine- and stress-induced secretion of ACTH and β-endorphin: Involvement of corticotropin-releasing hormone and vasopressin. Neuroendocrinology 56: 419-428.
142. Tozawa F, Suda T, Yamada M, Ushiyama T, Tomori N, Sumitomo T, Nakagami Y, Demura H, Shizume K (1988) Insulin-induced hypoglycemia increases proopiomelanocortin messenger ribonucleic acid levels in rat anterior pituitary gland. Endocrinology 122: 1231-1235.
143. Kjaer A, Knigge U, Madsen EL, Soe-Jensen P, Bach FW, Warberg J (1993) Insulin/hypoglycemia-induced adrenocorticotropin and β-endorphin release: Involvement of hypothalamic histaminergic neurons. Endocrinology 132: 2213-2220.
144. Kjaer A, Larsen P, Knigge U, Moller M, Warberg J (1994) Histamine stimulates c-fos expression in hypothalamic vasopressin-, oxytocin-, and corticotropin-releasing hormone-containing neurons. Endocrinology 134: 482-491.
145. Decavel C, Van Den Pol AN (1990) GABA: A dominant neurotransmitter in the hypothalamus. J Comp Neurol 302: 1019-1037.
146. Calogero AE, Gallucci WT, Chrousos GP, Gold PW (1988) Interaction between GABAergic neurotransmission and rat hypothalamic corticotropin-releasing hormone secretion in vitro. Brain Res 463: 28-36.
147. Makara GB, Stark E (1974) Effect of gamma-aminobutyric acid (GABA) and GABA antagonist drugs on ACTH release. Neuroendocrinology 16: 178-190.
148. Stotz-Potter EH, Morin SM, DiMicco JA (1996) Effect of microinjection of muscimol into the dorsomedial or paraventricular hypothalamic nucleus on air stress-induced neuroendocrine and cardiovascular changes in rats. Brain Res 742: 219-224.
149. Swanson LW, Cowan WM (1979) The connections of the septal region in the rat. J Comp Neurol 186: 621-656.
150. Kohler C (1990) Subicular projections to the hypothalamus and brainstem: Some novel aspects revealed in the rat by the anterograde Phaseolus vulgaris leukoagglutinin (PHA-L) tracing method. Prog Brain Res 83: 59-69.
151. Cullinan WE, Herman JP, Watson SJ (1993) Ventral subicular interaction with the hypothalamic paraventricular nucleus: Evidence for a relay in the bed nucleus of the stria terminalis. J Comp Neurol 322: 1-20.
152. Berkenbosch F, Van Oers J, Del Rey A, Tilders F, Besedovsky H (1987) Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-1. Science 238: 524-526.
153. Sapolsky R, Rivier C, Yamamoto G, Plotsky P, Vale W (1987) Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor. Science 238: 522-524.
154. Bernton EW, Beach JE, Holaday JW, Smallridge RC, Fein HG (1987) Release of multiple hormones by a direct action of interleukin-1 on pituitary cells. Science 238: 519-521.
155. Suda T, Tozawa F, Ushiyama T, Sumitomo T, Yamada M, Demura H (1990) Interleukin-1 stimulates corticotropin-releasing factor gene expression in rat hypothalamus. Endocrinology 126: 1223-1228.
156. Winter JSD, Gow KW, Perry YS, Greenberg AH (1990) A stimulatory effect of interleukin-1 on adrenocortical cortisol secretion mediated by prostaglandins. Endocrinology 127: 1904-1909.
157. Tominaga T, Fukata J, Naito Y, Usui T, Murakami N, Fukushima M, Nakai Y, Hirai Y, Imura H (1991) Prostaglandin-dependent in vitro stimulation of adrenocortical steroidogenesis by interleukins. Endocrinology 128: 526-531.
158. Uehara A, Gottshall PE, Dahl RR, Arimura A (1987) Interleukin-1 stimulates ACTH release by an action which requires endogenous corticotropin releasing factor. Endocrinology 121: 1580-1582.
159. Rivest S, Rivier C (1991) Influence of paraventricular nucleus of the hypothalamus in the alteration of neuroendocrine functions induced by intermittent footshock or interleukin. Endocrinology 129: 2049-2057.
160. Katsuura G, Arimura A, Koves K, Gottshall PE (1990) Involvement of organum vasculosum of lamina terminalis and preoptic area in interleukin 1β-induced ACTH release. Am J Physiol 258: E163-E171.
161. Ericsson A, Liu C, Hart RP, Sawchenko PE (1995) Type 1 interleukin-1 receptor in the rat brain: Distribution, regulation and relationship to sites of IL-1-induced cellular activation. J Comp Neurol 361: 681-698.
162. Weidenfeld J, Abramsky O, Ovadia H (1989) Evidence for the involvement of the central adrenergic system in interleukin 1-induced adrenocortical response. Neuropharmacology 28: 1411-1414.
163. Chuluyan HE, Saphier D, Rohn WM, Dunn AJ (1992) Noradrenergic innervation of the hypothalamus participates in adrenocortical responses to interleukin-1. Neuroendocrinology 56: 106-111.
164. Ericsson A, Kovacs KJ, Sawchenko PE (1994) A functional anatomical analysis of central pathways subserving the effects of interleukin-1 on stress-related neuroendocrine neurons. J Neurosci 14: 897-913.
165. Ban E, Milon G, Prudhomme N, Fillion G, Haour F (1991) Receptors for interleukin-1 (α and β) in mouse brain: Mapping and neuronal localization in hippocampus. Neuroscience 43: 21-30.
166. Cunningham ET Jr, Wada E, Carter DB, Tracey DE, Battey JF, De Souza EB (1992) In situ hiostochemical localization of type I interleukin-1 receptor messenger RNA in the central nervous system, pituitary and adrenal gland of the mouse. J Neurosci 12: 1101-1114.
167. Sawchenko PE, Swanson LW, Grzanna R, Howe PRC, Bloom SR, Polak JM (1985) Colocalization of neuropeptide Y immunoreactivity in brainstem catecholaminergic neurons that project to the paraventricular nucleus of the hypothalamus. J Comp Neurol 241: 138-153.
168. Bai FL, Yamano M, Shiotani Y, Emson PC, Smith AD, Powell JF, Tohyama M (1985) An arcuato-paraventricular and dorsomedial hypothalamic neuropeptide Y-containing system which lacks noradrenaline in the rat. Brain Res 331: 172-175.
169. Sawchenko PE, Pfeiffer SW (1988) Ultrastructural localization of neuropeptide Y and galanin immunoreactivity in the paraventricular nucleus of the hypothalamus in the rat. Brain Res 474: 231-245.
170. Suda T, Tozawa F, Iwai I, Sato Y, Sumitomo T, Nakano Y, Yamada M, Demura H (1993) Neuropeptide Y increases the corticotropin-releasing factor messenger ribonucleic acid level in the rat hypothalamus. Mol Brain Res 18: 311-315.
171. Lind RW, Swanson LW, Ganten D (1984) Angiotensin II immunoreactive pathways in the central nervous system of the rat: Evidence for a projection from the subfornical organ to the paraventricular nucleus of the hypothalamus. Clin Exp Hypertens A6: 1915-1920.
172. Sgro S, Ferguson AV, Renaud LP (1984) Subfornical organ-supraoptic nucleus connections: An electrophysiological study in the rat. Brain Res 303: 7-13.
173. Renaud LP, Ferguson AV, Day TA, Bourque CW, Sgro S (1985) Electrophysiology of the subfornical organ and its hypothalamic connections - An in vivo study in the rat. Brain Res Bull 15: 83-86.
174. Mendelsohn FAO, Quirion R, Saavedra JM, Aguilera G, Catt KJ (1984) Autoradiographic localization of angiotensin II receptors in rat brain. Proc Natl Acad Sci USA 81: 1575-1579.
175. Ferguson AV, Renaud LP (1986) Systemic angiotensin acts at subfornical organ to facilitate activity of neurohypophysial neurons. Am J Physiol 251: R712-R717.
176. Sumitomo T, Suda T, Nakano Y, Tozawa F, Yamada M, Demura H (1991) Angiotensin II increases the corticotropin-releasing factor messenger ribonucleic acid level in the rat hypothalamus. Endocrinology 128: 2248-2252.
177. Aguilera G, Young WS, Kiss A, Bathia A (1995) Direct regulation of hypothalamic corticotropin-releasing-hormone neurons by angiotensin II. Neuroendocrinology 61: 437-444.
178. Sawchenko PE, Swanson LW, Joseph SA (1982) The distribution and cells of origin of ACTH(1-39)-stained varicosities in the paraventricular and supraoptic nuclei. Brain Res 232: 365-374.
179. Kiss JZ, Cassell MD, Palkovits M (1984) Analysis of the ACTH/β-End/α-MSH immunoreactive afferent input to the hypothalamic paraventricular nucleus of rat. Brain Res 324: 91-99.
180. Suda T, Sato Y, Sumitomo T, Nakano Y, Tozawa F, Iwai I, Yamada M, Demura H (1992) β-endorphin inhibits hypoglycemia-induced gene expression of corticotropin-releasing factor in the rat hypothalamus. Endocrinology 130: 1325-1330.
181. Plotsky PM (1986) Opioid inhibition of immunoreactive corticotropin-releasing factor secretion into the hypophysial-portal circulation of rats. Regul Pept 16: 235-242.
182. Buckingham JC (1986) Stimulation and inhibition of corticotrophin releasing factor secretion by beta endorphin. Neuroendocrinology 42: 148-152.
183. Kamilaris TC, Johnson EO, Calogero AE, Kalogeras KT, Bernardini R, Chrousos GP, Gold PW (1992) Cholecystokinin-octapeptide stimulates hypothalamic-pituitary-adrenal function in rats: Role of corticotropin-releasing hormone. Endocrinology 130: 1764-1774.
184. Biro E, Sarnyai Z, Penke B, Szabo G, Telegdy G (1993) Role of endogenous corticotropin-releasing factor in mediation of neuroendocrine and behavioral responses to cholecystokinin octapeptide sulfate ester in rats. Neuroendocrinology 57: 340-345.
185. Larsen PJ, Jessop D, Patel H, Lightman SL, Chowdrey HS (1993) Substance P inhibits the release of anterior pituitary adrenocorticotropin via a central mechanism involving corticotropin-releasing factor-containing neurons in the hypothalamic paraventricular nucleus. J Neuroendocrinol 5: 99-105.
186. Bittencourt JC, Benoit R, Sawchenko PE (1991) Distribution and origins of substance P-immunoreactive projections to the paraventricular and supraoptic nuclei: Partial overlap with ascending catecholaminergic projections. J Chem Neuroanat 4: 63-78.
187. Buckingham JC, Cooper TA (1984) Differences in hypothalamo-pituitary-adrenocortical activity in the rat after acute and prolonged treatment with morphine. Neuroendocrinology 38: 411-417.
188. Buckingham JC (1982) Secretion of corticotropin and its hypothalamic releasing factor in response to morphine and opioid peptides. Neuroendocrinology 35: 111-116.
189. Brown MR, Rivier C, Vale W (1984) Central nervous system regulation of adrenocorticotropin secretion: Role of somatostatins. Endocrinology 114: 1546-1549.
190. Sawchenko PE, Benoit R, Brown MR (1988) Somatostatin 28-immunoreactive inputs to the paraventricular and supraoptic nuclei: Principal origin from non-aminergic neurons in the nucleus of the solitary tract. J Chem Neuroanat 1: 81-94.
191. Tempel DL, Leibowitz SF (1990) Galanin inhibits insulin and corticosterone release after injection into the PVN. Brain Res 536: 353-357.
192. Levin MC, Sawchenko PE, Howe PRC, Bloom SR, Polak JM (1987) Organization of galanin-immunoreactive inputs to the paraventricular nucleus with special reference to their relationship to catecholaminergic afferents. J Comp Neurol 261: 562-582.
193. Plotsky PM, Kjaer A, Sutton SW, Sawchenko PE, Vale W (1991) Central activin administration modulates corticotropin-releasing hormone and adrenocorticotropin secretion. Endocrinology 128: 2520-2525.
194. Sawchenko PE, Plotsky PM, Pfeiffer SW, Cunningham ET Jr, Vaughan J, Rivier J, Vale W (1988) Inhibin β in central neural pathways involved in the control of oxytocin secretion. Nature 334: 615-617.
195. Sawchenko PE, Arias C, Bittencourt JC (1990) Inhibin β, somatostatin, and enkephalin immunoreactivities coexist in caudal medullary neurons that project to the paraventricular nucleus of the hypothalamus. J Comp Neurol 291: 269-280.
196. Mandell AJ, Chapman LF, Rand RW, Walter RD (1963) Plasma corticosteroids: Changes in concentration after stimulation of hippocampus and amygdala. Science 139: 1212-1213.
197. Rubin RT, Mandell AJ, Crandall PH (1966) Corticosteroid responses to limbic stimulation in man: Localization of stimulus sites. Science 153: 767-768.
198. Wilson MM, Greer SE, Greer MA, Roberts L (1980) Hippocampal inhibition of pituitary-adrenocortical function in female rats. Brain Res 197: 433-441.
199. Fischette CT, Komisaruk BR, Edinger HM, Feder HH, Siegel A (1980) Differential fornix ablations and the circadian rhythmicity of adrenal corticosteroid secretion. Brain Res 195: 373-387.
200. Herman JP, Schafer MK-H, Young EA, Thompson R, Douglass J, Akil H, Watson SJ (1989) Evidence for hippocampal regulation of neuroendocrine neurons of the hypothalamo-pituitary-adrenocortical axis. J Neurosci 9: 3072-3082.
201. Herman JP, Cullinan WE, Young EA, Akil H, Watson SJ (1992) Selective forebrain fiber tract lesions implicate ventral hippocampal structures in tonic regulation of paraventricular nucleus corticotropin-releasing hormone (CRH) and arginine vasopressin (AVP) mRNA expression. Brain Res 592: 228-238.
202. Reul JMHM, de Kloet ER (1985) Two receptor systems for corticosterone in rat brain: Microdistribution and differential occupation. Endocrinology 117: 2505-2511.
203. Fuxe K, Wirkstrom A-C, Okret S, Agnati LF, Harfstrand A, Yu Z-Y, Granholm L, Zoli M, Vale W, Gustafsson J-A (1985) Mapping of glucocorticoid receptor immunoreactive neurons in the rat tel- and diencephalon using a monoclonal antibody against rat liver glucocorticoid receptor. Endocrinology 117: 1803-1812.
204. Herman JP, Patel P, Akil H, Watson SJ (1989) Localization and regulation of glucocorticoid and mineralocorticoid receptor messenger RNAs in the hippocampal formation of the rat. Mol Endocrinol 3: 1886-1894.
205. Sousa RJ, Tannery NH, Lafer EM (1989) In situ hybridization mapping of glucocorticoid receptor messenger ribonucleic acid in rat brain. Mol Endocrinol 3: 481-494.
206. Redgate ES, Fahringer EE (1973) A comparison of the pituitary adrenal activity elicited by electrical stimulation of preoptic, amygdaloid and hypothalamic sites in the rat brain. Neuroendocrinology 12: 334-343.
207. Van de Kar LD, Piechowski RA, Rittenhouse PA, Gray TS (1991) Amygdaloid lesions: Differential effect on conditioned stress and immobilization-induced increases in corticosterone and renin secretion. Neuroendocrinology 54: 89-95.
208. Gray TS, Carney ME, Magnuson DJ (1989) Direct projections from the central amygdaloid nucleus to the hypothalamic paraventricular nucleus: Possible role in stress-induced adrenocorticotropin release. Neuroendocrinology 50: 433-446.
209. Herman JP, Prewitt CM-F, Cullinan WE (1996) Neural circuit regulation of the hypothalamo-pituitary-adrenocortical stress axis. Critical Rev Neurobiol 10: 371-394.
210. Feldman S, Conforti N, Itzik A, Weidenfeld J (1994) Differential effect of amygdaloid lesions following neural stimuli. Brain Res 658: 21-26.
211. Herman JP, Cullinan WE, Watson SJ (1994) Involvement of the bed nucleus of the stria terminalis in tonic regulation of paraventricular hypothalamic CRH and AVP mRNA expression. J Neuroendocrinology 6: 433-442.